More than six million Americans age 65 and up are living with Alzheimer’s including more than 35,000 Nebraska residents.

Zunveyl, an oral medication, is a better-tolerated version of galantamine for managing mild to moderate Alzheimer's symptoms.

This has demonstrated the potential of palbociclib in treating Alzheimer’s disease,” Chen said. The research shows the drug ...

Discover how dopamine’s unexpected role in breaking down harmful plaques could revolutionize Alzheimer's treatment and ...

Researchers have discovered that suppressing a nucleolar complex can reduce Alzheimer’s-related protein toxicity. Scientists ...

A recent study has linked thyroid and liver proteins, transthyretin (TTR) and apolipoprotein A-I (ApoA-I), to brain health, ...

Sleep disorders seem to be common in people with Alzheimer’s disease. Melatonin may help treat sleep disorders caused by Alzheimer’s disease. It may also help reduce neurological damage in the ...

A new surgical treatment for Alzheimer’s disease is showing promise in a clinical trial under way in Chinese hospitals. One ...

It is believed most humans are ... First Successful Clinical Trial of VU319 Brings Alzheimer's Treatment One Step Closer Dec. 19, 2024 — Phase I clinical trial of a drug was successfully ...

There is a potential link between Alzheimer's disease and the herpes simplex virus-1 (HSV-1), which is a common cause for ...